AU2014215992B2 - A composition containing a bisphosphonic acid in combination with vitamin D - Google Patents

A composition containing a bisphosphonic acid in combination with vitamin D

Info

Publication number
AU2014215992B2
AU2014215992B2 AU2014215992A AU2014215992A AU2014215992B2 AU 2014215992 B2 AU2014215992 B2 AU 2014215992B2 AU 2014215992 A AU2014215992 A AU 2014215992A AU 2014215992 A AU2014215992 A AU 2014215992A AU 2014215992 B2 AU2014215992 B2 AU 2014215992B2
Authority
AU
Australia
Prior art keywords
vitamin
combination
bisphosphonic acid
composition containing
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2014215992A
Other versions
AU2014215992A1 (en
Inventor
Mostafa Akbarieh
Fazal M. Mohideen
Shetal Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Pharmaceuticals ULC
Original Assignee
Mylan Pharmaceuticals ULC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007335155A external-priority patent/AU2007335155A1/en
Application filed by Mylan Pharmaceuticals ULC filed Critical Mylan Pharmaceuticals ULC
Priority to AU2014215992A priority Critical patent/AU2014215992B2/en
Publication of AU2014215992A1 publication Critical patent/AU2014215992A1/en
Application granted granted Critical
Publication of AU2014215992B2 publication Critical patent/AU2014215992B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to pharmaceutical compositions containing a ) bisphosphonic acid in combination with a non-activated metabolite of vitamin D for oral administration. The compositions of the invention either do not contain or contain only low concentrations of a glidant. Also provided are methods for preparing such compositions and methods of use thereof, for preventing or treating abnormal bone resorption in mammals.
AU2014215992A 2006-12-20 2014-08-21 A composition containing a bisphosphonic acid in combination with vitamin D Ceased AU2014215992B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014215992A AU2014215992B2 (en) 2006-12-20 2014-08-21 A composition containing a bisphosphonic acid in combination with vitamin D

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA2,571,398 2006-12-20
CA2,571,538 2006-12-20
AU2007335155A AU2007335155A1 (en) 2006-12-20 2007-12-19 A composition containing a bisphosphonic acid in combination with vitamin D
AU2014215992A AU2014215992B2 (en) 2006-12-20 2014-08-21 A composition containing a bisphosphonic acid in combination with vitamin D

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2007335155A Division AU2007335155A1 (en) 2006-12-20 2007-12-19 A composition containing a bisphosphonic acid in combination with vitamin D

Publications (2)

Publication Number Publication Date
AU2014215992A1 AU2014215992A1 (en) 2014-09-11
AU2014215992B2 true AU2014215992B2 (en) 2016-07-14

Family

ID=51494585

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014215992A Ceased AU2014215992B2 (en) 2006-12-20 2014-08-21 A composition containing a bisphosphonic acid in combination with vitamin D

Country Status (1)

Country Link
AU (1) AU2014215992B2 (en)

Also Published As

Publication number Publication date
AU2014215992A1 (en) 2014-09-11

Similar Documents

Publication Publication Date Title
SG171649A1 (en) Dpp iv inhibitor formulations
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
EP2401997A3 (en) Dental compositions with calcium phosphorus releasing glass
UA100228C2 (en) Pharmaceutical composition containing a tetrahydrofolic acid
MY143795A (en) Tetrahydropyridoindole derivatives
EP3895699A3 (en) Pharmaceutical compositions comprising iron oxy-hydroxide
MY138708A (en) Biaryloxymethylarenecarboxylic acids
BRPI0508579A (en) compound, pharmaceutical composition, and use of a compound
MX2011012122A (en) Thiophene derivatives.
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
MX2009006447A (en) Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate.
MX2009013501A (en) Piperidine compounds and uses thereof.
IL193024A0 (en) Levetiracetam formulations and methods for their manufacture
TNSN08451A1 (en) Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
MX2008001560A (en) Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds.
WO2008113901A3 (en) Composition with controlled release of levetiracetam and method for preparing same
MX2009003169A (en) Sulfonamide derivatives.
SG10201406846XA (en) Bisphosphonate compounds for treating bone metabolism disorders
HK1123986A1 (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
WO2010033981A3 (en) 5-azaindole bisphosphonates
WO2010033980A3 (en) 4-azaindole bisphosphonates
GB0615105D0 (en) Novel compounds
AU2014215992B2 (en) A composition containing a bisphosphonic acid in combination with vitamin D
WO2005082862A3 (en) Benzimidazolyl derivatives as kinase inhibitors
WO2007121471A3 (en) Dialkyl ether delivery agents

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired